2020 annual financial data
Keros Therapeutics 2020 Operating margin
Keros Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -1,866.28%.
Operating income was -46,657,000 USD and net income was -45,361,000 USD.
Operating cash flow was -36,894,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,500,000 USD
- Operating income
- -46,657,000 USD
- Net income
- -45,361,000 USD
- Operating cash flow
- -36,894,000 USD